Expression of the MutL homologue hMLH3 in human cells and its role in DNA mismatch repair

The human mismatch repair (MMR) proteins MLH1 and hPMS2 function in MMR as a heterodimer. Cells lacking either protein have a strong mutator phenotype and display micro-satellite instability, yet mutations in the hMLH1 gene account for similar to 50% of hereditary nonpolyposis colon cancer families, whereas hPMS2 mutations are substantially less frequent and less penetrant. Similarly, in the mouse model, Mlh1(-/-) animals are highly cancer prone and present with gastrointestinal tumors at an early age, whereas Pms2(-/-) mice succumb to cancer much later in life and do not present with gastrointestinal tumors. This evidence suggested that MLH1 might functionally interact with another MutL homologue, which compensates, at least in part, for a deficiency in PMS2. Sterility of Mlh1(-/-) Pms2(-/-) and Mlh3(-/-) mice implicated the Mlh1/ Pms2 and Mlh1/Mlh3 heterodimers in meiotic recombination. We now show that the hMLH1/hMLH3 heterodimer, hMutL gamma, can also assist in the repair of base-base mismatches and single extrahelical nucleotides in vitro. Analysis of hMLH3 expression in colon cancer cell lines indicated that the protein levels vary substantially and independently of hMLH1. If hMLH3 participates in MMR in vivo, its partial redundancy with hPMS2, coupled with the fluctuating expression levels of hMLH3, may help explain the low penetrance of hPMS2 mutations in hereditary nonpolyposis colon cancer families. (Cancer Res 2005; 65(23): 10759-66).